| abstract |
The present invention discloses complexes of the CDK2 protein with proteins identified as interacting with the CDK2 protein (CDK2 protein-IPs) by a modified, improved yeast two hybrid assay system. The proteins which were identified to interact with the CDK2 protein, and thus form complexes, included: cyclin I, ERH, hsReq*-1 and hsReq*-2, as well as derivatives, fragments analogs and homologs thereof. The invention also provides nucleic acids encoding the hsReq*-1 and hsReq*-2 nucleotide sequences, and proteins and derivatives, fragments and analogs thereof. Methodologies of screening these aforementioned complexes for efficacy in treating and/or preventing various diseases and disorders, particularly neoplasia and atherosclerosis, are also disclosed herein. |